The effects of insulin and glucose on the oxidative decarboxylation of pyruvate in isolated rat hindlimbs was studied in non-recirculating perfusion with [1-'4C]pyruvate. Insulin increased the calculated pyruvate decarboxylation rate in a concentration-dependent manner. At supramaximal insulin concentrations, the calculated pyruvate decarboxylation rate was increased by about 40% in perfusions with 0.15-1.5mM-pyruvate. Glucose up to 20mM had no effect. In the presence of insulin and low physiological pyruvate concentrations (0.15mM), glucose increased the calculated pyruvate oxidation. This effect was abolished by high concentrations of pyruvate (1 mM). The data provide evidence that in resting perfused rat skeletal muscle insulin primarily increased the activity of the pyruvate dehydrogenase complex. The effect of glucose was due to increased intracellular pyruvate supply.
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Oxidative decarboxylation of pyruvate by the mitochondrial pyruvate dehydrogenase complex (EC 1.2.4.1, EC 2.3.1.12, EC 1.6.4.3) is a key reaction in carbohydrate metabolism. A wide variety of factors, including substrate, coenzyme and ion concentrations, have been shown to influence the activity of the complex by either activating or inhibiting the components of the interconversion system and/or by feedback inhibition of the active dephosphorylated form (for reviews, see Denton et al., 1975; Denton & Hughes, 1978; Reed, 1981; Wieland, 1983) . Different experimental approaches have been used for studies on the regulation of pyruvate decarboxylation in intact tissues. Determination of the activation state of the pyruvate dehydrogenase complex primarily yielded information on the actual and total capacity in a tissue (Coore et al., 1971; Siess et al., 1971; Wieland et al., 1971; Hennig et al., 1975; Hagg et al., 1976; Stansbie, 1976) . '4C02 release from [1-'4C]pyruvate has been used, e.g. in the perfused rat liver (Haussinger et al., 1975; Scholz et al., 1978; Patel et al., 1982; Zwiebel et al., 1982; Sies et al., 1983) , heart (Hiltunen & Hassinen, 1976; Dennis et al., 1979; Waymack et al., 1979; Bunger et al., 1983) , and skeletal muscle (Schadewaldt et al., 1983b,c) (Jungas, 1971 ; for further references see Denton & Hughes, 1978) and the lactating mammary gland (Kankel & Reinauer, 1976; Baxter & Coore, 1978) . Contradictory results have been reported for the rat heart (Kerbey et al., 1976; Ohlen et al., 1978) and liver (Patzelt et al., 1973; Topping et al., 1977 Hennig et al. (1975) , and studies on the putative intracellular mediator of insulin (Jarett & Seals, 1979; Larner et al., 1979) (Hansford & Cohen, 1978; Dennis et al., 1979; Waymack et al., 1979; Bunger et al., 1983) . Therefore the effects of insulin and glucose on the metabolism of [1-'4C]pyruvate in isolated perfused rat hindlimbs were investigated. The preparation has been widely used for the study of skeletal-muscle Vol. 227 metabolism (Ruderman et al., 1971) and offers the advantage of metabolic and isotopic steady-state conditions in non-recirculating perfusion. Preliminary results have been presented (Schadewaldt et al., 1983a (Schadewaldt et al., , 1984a .
Experimental
Hindlimbs of fed male rats (Wistar strain, 180-200g body wt.) were prepared essentially as described by Ruderman et al. (1971) . Nonrecirculating perfusion of one limb with a medium containing 0.15mM-sodium pyruvate was carried out as described by Schadewaldt et al. (1983c) . Additions to the influent were made with infusion pumps. Insulin, diluted with 0.154M-NaCl, and the other reagents in water solution were infused to give the final arterial concentrations as indicated.
Tracer doses of [1-14C] pyruvate MBq/mmol) were added to give specific radioactivities of 1.3-2.6Bq/nmol of influent pyruvate.
The concentrations of lactate (Gutmann & Wahlefeld, 1974) , pyruvate (Czok & Lamprecht, 1974) and glucose (Bergmeyer et al., 1974) in the perfusate were determined by spectrophotometric methods. 14CO2 production from [1-14C]pyruvate was used to calculate the 14CO2 release rate on the basis of the specific radioactivity of pyruvate in the perfusate. Likewise, the pyruvate decarboxylation rate in the perfused tissue was calculated on the basis of the specific radioactivity of lactate in the effluent. The specific radioactivity of lactate in the effluent was determined as detailed elsewhere (Schadewaldt et al., 1984b) , and largely reflects the intracellular dilution of influent[-1-14C]pyruvate during perfusion (Schadewaldt et al., 1983c) .
The glycolytic rate in the perfused tissue was calculated from the lactate-release and pyruvatedecarboxylation rates and was corrected for pyruvate uptake. Insulin concentrations were calculated (7.2 nmol = 1 i.u.) from the units added to the perfusate (see Rennie & Holloszy, 1977 The sources for the other materials were as in Schadewaldt et al. (1984b) .
Results

Effect of insulin
The effect of insulin was first studied in glucosefree perfusion. As shown in Fig. 1 , a concentration- *.dependent effect of insulin on the 14C02 release from [1-'4C]pyruvate was observed. No significant effects were measurable with low insulin concentrations (36 pM). Addition of physiological insulin concentrations (145pM; n = 4) significantly enhanced the pyruvate uptake by about 7% from 56+20 to 60 + 18 nmol/min per g of muscle (P<0.05), and the 14CO2 release by 20+9% (P < 0.01). The specific radioactivity of lactate was decreased from 134+27 to 120+26 Bq/nmol (P<0.02). Because this appears as the denominator in the calculation, it has a major effect on the more distinct increase in the calculated pyruvate decarboxylation rate after addition of insulin (Fig. 1) .
The effects on the l4CO2 release and the calculated pyruvate decarboxylation rate were more marked at higher insulin concentrations. Above 1.45 nM-insulin no further increase was measurable. The results obtained with supramaximal insulin concentration, i.e. 7.2nM, on metabolic rates and [1-'4C]pyruvate metabolism in glucosefree perfusions are included in Tables 1 and 3 respectively.
1985
Effect of glucose Some effects of glucose (5mM) on the metabolism of rat hindlimbs in insulin-free perfusion are shown in Table 1 . Under standard perfusion conditions, low amounts of glucose were released into the perfusate, corresponding to about 15% of the glucose arising from muscle glycogen breakdown (cf. Schadewaldt et al., 1983b) . After addition of 5mM-glucose a net uptake was observed. The release of lactate and the glycolytic rate were increased, whereas the pyruvate uptake was slightly decreased.
Glucose affected [1-'4C]pyruvate metabolism in a concentration-dependent manner ( Table 2 ). The 14CO2 release and concomitantly the specific radioactivity of lactate were decreased, indicatingan increased dilution of label within the perfused tissue. However, the calculated pyruvate decarboxylation rate remained unchanged up to 20mM-glucose.
Combination of insulin and glucose
The usual experimental procedure and a representative experiment is shown in Fig. 2 (Table 3) .
In contrast with the lack of effect of glucose on the calculated pyruvate decarboxylation rate in the absence of insulin, an effect of perfusate glucose was observed in the presence of insulin (Fig. 2,  Table 3 ). With respect to the insulin-and glucosefree perfused control, there was an increase amounting to about 20, 30, and 50% at 1 mM-,5 mMand 10mM-glucose respectively. No further increase was seen at 20mM-glucose (Table 3) .
Effect ofpyruvate
Compared with the insulin-free control phase of perfusion (cf. Fig. 2 ), the calculated pyruvate decarboxylation rate was significantly enhanced in perfusions with elevated pyruvate concentrations. Table 1 . Efject of glucose on metabolic rates in isolated perfused rat hindlimbs in the absence and presence of insulin Data are from separate experiments without and with addition of insulin. Non-recirculating perfusion with 0.15 mM-pyruvate in the absence of insulin was carried out for 20-25 min, followed by a 20 min period of perfusion with additional 5mM-glucose. Perfusions with insulin were performed essentially as shown in Fig. 2 Fig. 2 . In these experiments (results not shown) the calculated pyruvate decarboxylation rate remained essentially unchanged on addition of 5 mM-glucose.
Discussion
Methodology Under the perfusion conditions used the metabolism of 15-17 g of skeletal muscle was investigated. However, the preparation contains about 1.5 g of adipose tissue (Ruderman et al., 1971) , which might interfere with the interpretation of insulin effects on skeletal-muscle metabolism. In adipose tissue incubated with glucose, insulin induced a large increase in the activation state of the pyruvate dehydrogenase complex. However, no insulin effect could be observed in most studies when glucose was omitted from the medium (for references, see Denton & Hughes, 1978; Wieland, 1983) . It therefore seems unlikely that adipose tissue contributed significantly to insulin effects in glucose-free perfusions.
In hindlimb perfusions with glucose and supramaximal concentrations of insulin, adipose-tissue pyruvate catabolism could possibly not exceed 10% of the calculated total pyruvate decarboxylation rate (cf. Table 3 ), whether estimated on the basis of oxygen consumption (about 3% of total; cf. Ruderman et al., 1971; Schadewaldt et al., 1983c) or on the basis of total pyruvate dehydrogenase in this tissue (Hennig et al., 1975) .
Effect of glucose and pyruvate
In perfusions with 0.15mM-pyruvate, pyruvate was taken up in spite of high glycolytic rate, and hence pyruvate production rate, in the perfused muscle tissue. The uptake was only slightly decreased by addition of glucose. These observations provide evidence that the availability of pyruvate emerging from glycolysis was limited for the pyruvate dehydrogenase reaction and indicate an impaired substrate supply in the insulin-free perfused tissue even in the presence of glucose. That intracellular substrate availability is important for the overall flux through the enzyme is further suggested by the increased pyruvate decarboxylation at elevated perfusate pyruvate concentrations.
Pyruvate is an inhibitor of the pyruvate dehydrogenase kinase (Linn et al., 1969; Cooper et al., 1974) , and can thus increase the activation state of the complex. However, in the perfused rat heart the activation state has been found to be decreased with increasing perfusate pyruvate concentrations (Dennis et al., 1979 ). An increased activation state could only be demonstrated with pyruvate concentrations above 2mM (Bunger et al., 1983; Dennis et al., 1979) . Therefore, and because of the linear relationship shown in Fig. 3 , it seems rather Vol. 227 unlikely that pyruvate affected the pyruvate flux in resting perfused rat skeletal muscle to a significant extent by inhibition of the pyruvate dehydrogenase kinase at pyruvate concentrations used in this study.
Whether and to what extent glucose in the presence of insulin might influence the cytosolic and, moreover, the mitochondrial pyruvate concentration in skeletal muscle is actually not known. The concentration-dependent effect of glucose to increase the calculated pyruvate decarboxylation rate and the considerable decrease in net pyruvate uptake by glucose in perfusions with insulin would, however, be reasonably explained by an improvement of intracellular pyruvate supply. The finding that the insulin-dependent effect of glucose was abolished by addition of 1 mM-pyruvate further supports this view.
Effect of insulin
The experiments demonstrate an increasing effect of physiological insulin concentrations on the pyruvate decarboxylation in glucose-free perfused hindlimbs of fed rats. The dose-response relationship is comparable with the effects of insulin on glycogen metabolism in perfused rat hindquarters (Chiasson et al., 1980) . From the activation states of the pyruvate dehydrogenase in resting gastrocnemius muscles of normal and insulin-deficient rats reported by Hagg et al. (1976) and Hennig et al. (1975) and the maximal pyruvate decarboxylation rates in the present study, the total enzyme activity in the perfused tissue can be estimated. It amounted to about 2units/g of muscle, in both the absence and the presence of insulin. This agrees well with the values given by Hennig et al. (1975) .
In the concentration range 0.15-1.5mM-pyruvate, insulin increased the calculated pyruvate flux by about 40% with respect to the insulin-free perfused control. Thus the effect of insulin was apparently independent of the perfusate pyruvate concentration and contrasts with the effect of glucose.
Pyruvate is taken up by the perfused tissue. Therefore the concentration of pyruvate with halfmaximal effect on the pyruvate flux is somewhat overestimated. Nevertheless, the data indicate that half-maximally effective pyruvate concentrations are in the physiological range. When compared with the apparent Km of pyruvate dehydrogenase, about 0.02mM (Cooper et al., 1974; Taylor & Halperin, 1973) , and with that of the mitochondrial pyruvate carrier, about 0.15 mM (Halestrap, 1975) , it appears that the concentration of pyruvate with half-maximal effect on flux was closer to the apparent Km of the carrier than to that of the enzyme. Whether this indicates a regulatory role of the carrier, as has been proposed for the perfused rat heart (Waymack et al., 1979) and liver (Zwiebel et al., 1982) , is unclear. In any case, it may be deduced that, in perfused skeletal muscle, carriermediated transport into the mitochondrial compartment is not a site of hormonal regulation by insulin.
The evidence presented-so far suggests that the insulin-induced increase in pyruvate catabolism in glucose-free perfused rat hindlimbs was primarily attributable to an increased activity of the pyruvate dehydrogenase complex. At the present state of knowledge, no reliable conclusion can be drawn on the ultimate mechanism. Whether insulin effects were due to the release of a mediator with direct influence on the interconversion system or were rather a consequence of decreased acetylCoA production from endogenous lipid stores (Ruderman et al., 1971) remains to be investigated.
Compared with the marked effects of electrical stimulation on the activation state of the pyruvate dehydrogenase complex in gastrocnemius muscles of normal and diabetic rats (Hagg et al., 1976; Hennig et al., 1975) , the influence of insulin on pyruvate catabolism in resting perfused skeletal muscle was only moderate. Therefore factors other than insulin, e.g. Ca2 , seem to be of major importance for the regulation of pyruvate oxidation in skeletal muscle during the transition from rest to contraction. 
